Breaking News Instant updates and real-time market news.

CI

Cigna

$212.38

-0.625 (-0.29%)

, EGN

Energen

$69.80

0.68 (0.98%)

17:23
11/14/18
11/14
17:23
11/14/18
17:23

Icahn exits Cigna, boosts Energen, Newell Brands stakes in Q3

Carl Icahn's Icahn Capital disclosed in an SEC filing its holdings as of September 30, 2018. Icahn exited one position during the third quarter, Cigna (CI). Icahn increased its stake in four holdings, including by size of previous position, Energen (EGN), Icahn Enterprises (IEP), and Newell Brands (NWL). Icahn reduced its stake in two holdings, which were, by size of previous position, VMware (VMW) and Cheniere Energy (LNG). Icahn's top holdings as of September 30, 2018, in order of size, were Icahn Enterprises, CVR Energy (CVI), Herbalife (HLF), Cheniere Energy, and Newell Brands.

CI

Cigna

$212.38

-0.625 (-0.29%)

EGN

Energen

$69.80

0.68 (0.98%)

IEP

Icahn Enterprises

$67.89

-1.41 (-2.03%)

NWL

Newell Brands

$20.63

0.1 (0.49%)

VMW

VMware

$152.41

1.86 (1.24%)

LNG

Cheniere Energy

$58.54

-1.07 (-1.80%)

CVI

CVR Energy

$37.97

-0.53 (-1.38%)

HLF

Herbalife Nutrition

$54.70

-0.35 (-0.64%)

  • 06

    Dec

  • 10

    Jan

CI Cigna
$212.38

-0.625 (-0.29%)

11/01/18
RBCM
11/01/18
NO CHANGE
Target $101
RBCM
Outperform
Express Scripts price target raised to $101 from $94 at RBC Capital
RBC Capital analyst George Hill raised his price target on Express Scripts (ESRX) to $101 and kept his Outperform rating after the company posted a "solid" Q3. The analyst notes that investors continue to focus on the company's merger with Cigna (CI) after the combination received a DoJ approval, adding that the price target revision was also set to reflect the current Cigna stock price.
11/01/18
LEER
11/01/18
NO CHANGE
Target $100
LEER
Market Perform
Express Scripts price target raised to $100 from $95 at Leerink
Leerink analyst David Larsen raised his price target for Express Scripts (ESRX) to $100 from $95 after the company reported "good" Q3 results. Following shareholder and DOJ approval on 9/17 for the pending merger with Cigna (CI), the analyst remains confident the deal will close, especially given this quarter's results. The companies continue to believe the deal will be completed by December 31, 2018, he notes. Larsen reiterates a Market Perform rating on Express Scripts' shares.
10/12/18
JEFF
10/12/18
DOWNGRADE
JEFF
Hold
Molina Healthcare downgraded to Hold on valuation at Jefferies
Jefferies analyst David Windley downgraded Molina Healthcare (MOH) to Hold with an unchanged price target of $152. The downgrade is based mostly on valuation as the company has pulled forward "significant earnings power faster than expected" and appreciated 80% year-to-date, Windley tells investors in a research note. The analyst, however, remains constructive on Managed Care fundamentals with a bias to own diversified insurers. He likes we like UnitedHealth's (UNH) Q4 set-up and also believe Cigna's (CI) multiple can expand.
10/03/18
10/03/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. HSBC CUTS NIKE TO HOLD: HSBC analyst Erwan Rambourg downgraded Nike (NKE) to Hold from Buy and kept his $92 price target on shares. The analyst noted that while the company's Q1 results were strong and the outlook "remains rock solid", the company's valuation multiple of 30-times forward earnings may weigh on the stock. EVERCORE CUTS ORACLE TO IN LINE: Evercore ISI analyst Kirk Materne downgraded Oracle (ORCL) to In Line from Outperform with a price target of $53 to reflect the update of his model into FY20. The analyst noted that even though growth is expected to accelerate modestly in the second half of this year, there are not enough catalysts for share to "meaningfully re-rate" from current levels, adding that the risk-reward appears balanced following this summer's rally. CIGNA BOOSTED TO CONVICTION BUY AT GOLDMAN: Goldman Sachs analyst Stephen Tanal added Buy-rated Cigna (CI) to his firm's Conviction List and raised his price target for the shares to $250 from $227. After revisiting the company's fundamental story, the analyst continues to believe Cigna is well positioned to take share of the U.S. commercial market. He believes fundamentals support a higher standalone multiple. CREDIT SUISSE DOWNGRADES HI-CRUSH, COVIA: Credit Suisse analyst Jim Wicklund downgraded Hi-Crush Partners (HCLP) to Neutral from Outperform and Covia (CVIA) to Underperform from Neutral. The analyst noted that the weakness that has rippled through the frack sand subsector since August came sooner than he expected. The ferocity of price competition, based on commentary from the sand companies in addition to their OFS and E&P customers, is also greater than he had expected, he added. In late morning trading, Hi-Crush was down almost 2%, while Covia was down just over 4%. GOLDMAN RAISES ALIBABA'S PRICE TARGET: Goldman Sachs analyst Piyush Mubayi reiterated a Buy rating on Alibaba (BABA) and raised his price target to $247 from $241. The analyst predicts strong growth in the cloud computing and financial businesses for the company, and expects Alibaba to continue to invest for future growth on "multiple fronts," including retailing, digital advertising and entertainment, which he believes will be a total addressable market of about RMB80T by the end of 2020.
EGN Energen
$69.80

0.68 (0.98%)

09/11/18
ARGS
09/11/18
DOWNGRADE
ARGS
Hold
Energen downgraded to Hold at Argus on buyout
As reported earlier, Argus analyst Bill Selesky downgraded Energen (EGN) to Hold after the announcement of its $9.2B buyout by Diamondback Energy (FANG). The analyst notes that there upside to his prior price target of $74 is limited from current levels and justifies a neutral stance, adding that while both boards have approved the deal, it still requires shareholder approval.
09/19/18
NASC
09/19/18
DOWNGRADE
NASC
Hold
Energen downgraded to Hold from Buy at National Alliance
09/07/18
GHSC
09/07/18
DOWNGRADE
Target $73
GHSC
Neutral
Energen downgraded to Neutral from Buy at Seaport Global
Seaport Global analyst Mike Kelly downgraded Energen (EGN) to Neutral from Buy with a $73 price target due to the pending acquisition by Diamondback Energy (FANG).
09/11/18
ARGS
09/11/18
DOWNGRADE
ARGS
Hold
Energen downgraded to Hold from Buy at Argus
IEP Icahn Enterprises
$67.89

-1.41 (-2.03%)

03/19/18
WELS
03/19/18
NO CHANGE
Target $25
WELS
Market Perform
Newell Brands agreement with Icahn lends credibility to management plan, says Wells Fargo
Wells Fargo analyst Bonnie Herzog says Newell Brands (NWL) agreement with Carl Icahn, Chairman of Icahn Enterprises (IEP), lends credibility to the management's plan, and likely increases the odds that the former will ultimately prevail in its proxy battle with Starboard. That said, the analyst believes that ongoing fundamental headwinds, the stepped-up divestiture program and organizational disruption likely leaves an overhang on the shares, despite a cheap valuation. Herzog reiterates a Market Perform rating and $25 price target on Newell's shares.
03/19/18
JEFF
03/19/18
NO CHANGE
JEFF
Newell Brands agreement with Icahn a win for CEO Polk, says Jefferies
Jefferies analyst Kevin Grundy noted that Newell Brands reached an agreement with activist investor Carl Icahn to appoint five directors nominated by Icahn to the company's board, a board which totals eleven directors. In exchange, Icahn agreed to vote all his shares -- he disclosed a 6.9% stake in Newell -- in favor of Newell's nominees. The firm believes that while this news may come as a surprise, it will lead to the shares trading up, and called it a "big win" for CEO Michael Polk, despite the five seats given up being "a hefty price." Jefferies maintained a Hold rating and $29 price target on Newell shares.
NWL Newell Brands
$20.63

0.1 (0.49%)

09/24/18
WELS
09/24/18
NO CHANGE
WELS
Outperform
Newell weakness on potential Sears bankruptcy fears overdone, says Wells Fargo
Wells Fargo analyst Bonnie Herzog believes today's weakness in shares of Newell Brands (NWL) is likely due to concerns about a potential bankruptcy of Sears (SHLD) as well as ongoing China tariff negotiations. However, she views the move as a "complete overreaction," arguing that Newell's exposure to Sears is fairly limited. Herzog, who sees today's weakness as overblown and would be a buyer amid the weakness, reiterates her Outperform rating on Newell shares, which are down 7% to $20.28 in late morning trading.
09/20/18
WELS
09/20/18
NO CHANGE
Target $33
WELS
Outperform
Wells sees 'significant' upside in Newell, even in bear case scenario
Wells Fargo analyst Bonnie Herzog continues to see value in Newell Brands that she thinks the Street is missing. The analyst believes Newell's $10B divestiture plan will "unlock significant value" and leave a "simpler, faster growing" company with "significant" exposure to e-commerce "that should ultimately garner a higher multiple." Additional divestiture announcements and a better fundamental outlook for the second half of 2018 provide near-term catalysts for the shares, Herzog tells investors in a research note titled "We See Significant Upside Potential Even In Bear Case Scenario." The analyst sees limited downside risk to current share levels and believes the new board is highly focused on unlocking value. She thinks that if the shares remain weak, the board would not hesitate to explore more aggressive actions like a management change or complete break-up. Herzog sees a favorable risk/reward, with potential 17% upside in a bear case and 75% upside in a bull case. She reiterates an Outperform rating on Newell Brands with a $33 price target.
11/05/18
BMOC
11/05/18
NO CHANGE
Target $20
BMOC
Market Perform
Newell Brands price target lowered to $20 from $25 at BMO Capital
BMO Capital analyst Shannon Coyne lowered the price target on Newell Brands to $20, saying its Q3 earnings of 81c included a tax benefit. The analyst notes that while the company may have turned the corner with accelerating sales and operating margin improvement, it is also faced with "persistent headwinds in appliances/baby/home fragrance/Coleman" categories along with rising input cost and tariff risks. Coyne keeps Newell Brands rating at Market Perform.
11/05/18
JEFF
11/05/18
NO CHANGE
Target $20
JEFF
Hold
Newell Brands price target lowered to $20 from $23 at Jefferies
Jefferies analyst Kevin Grundy lowered his price target for Newell Brands to $20 following the company's "mixed" Q3 results. While below Street estimates, Newell's Q3 core sales improved sequentially and "cleared the low bar," Grundy tells investors in a research note. Further, he believes the return to growth in Writing is encouraging. However, results missed expectations in the remainder of Newell's portfolio and "myriad risks remain," including tariffs, says Grundy. The analyst remains on the sidelines with a Hold rating.
VMW VMware
$152.41

1.86 (1.24%)

11/14/18
CLVD
11/14/18
NO CHANGE
CLVD
Buy
Cleveland Research encourages investors to own VMware
VMware analyst Ben Bollin's checks indicate an uptick in Buy rated VMware performance with a number of partners exceeding target prior to quarter end. Billing remains favorable on VMware's near-term opportunity with favorable adoption of EUC, storage, compute, and networking and encourages investors to own shares. The analyst also said consensus estimates appear conservative and sees a number of catalysts that support +10.5% upside to FY20 revenue growth assumptions.
11/06/18
JEFF
11/06/18
NO CHANGE
Target $186
JEFF
Buy
VMware acquisition of Heptio makes sense, says Jefferies
Jefferies analyst John DiFucci believes VMware's acquisition of Heptio makes sense, as it "fits squarely into the company's broader Software-Defined Data Center strategy." The analyst believes VMware has adapted to the rising proliferation of container-based environments and he keeps a Buy rating on the shares with a $186 price target.
10/19/18
WEDB
10/19/18
INITIATION
Target $185
WEDB
Outperform
VMware initiated with an Outperform at Wedbush, added to Best Ideas List
Wedbush analyst Daniel Ives initiated VMware (VMW) with an Outperform rating and $185 price target and added the stock to the Best Ideas List. In a research note to investors, Ives says he believes VMware has a number of tailwinds heading into FY19 including a healthy ELA renewal cycle, strong customer interest around its vSphere solution as more enterprises aggressively embrace the cloud, and incremental growth from its NSX segment that we believe in particular could be a major growth driver for the coming years. With the current bid for Dell Technologies tracking stock (DVMT) undervaluing the inherent value of this stock, Ives believes an investor showdown is on the horizon as the Street joins forces in its battle vs. Michael Dell/Silver Lake in this path to take Dell public again and thus represents a potential wild card for VMware and its investors looking ahead.
10/29/18
MSCO
10/29/18
NO CHANGE
MSCO
IBM deal reinforces Morgan Stanley confidence in Hybrid Cloud emergence
After IBM (IBM) announced its intention to acquire Red Hat (RHT) for about $34B in a deal with an over 60% premium to Red Hat's Friday closing price, Morgan Stanley analyst Keith Weiss said the announcement reinforced both his confidence in the emergence of Hybrid Cloud architectures and the strength of IT spending into 2019. Red Hat has been Microsoft's (MSFT) primary competitor within server operating systems, and has generally been taking share, said Weiss, who thinks the longer-term opportunity or threat for Microsoft hinges on the ability of IBM to execute well and maintain the open source enthusiasm around the Red Hat distributions. For VMware (VMW) and Pivotal Software (PVTL), while Weiss sees little near-term impact, he adds that the proposed combination would likely result in a fiercer competitive environment going forward. For New Relic (NEWR), he sees little direct competitive impacts from the proposed merger. Given HortonWorks' (HDP) strong existing ties to IBM, Cloudera (CLDR) could benefit by becoming a preferred data management vendor within the OpenShift ecosystem, Weiss added.
LNG Cheniere Energy
$58.54

-1.07 (-1.80%)

10/31/18
JPMS
10/31/18
INITIATION
Target $84
JPMS
Overweight
Cheniere Energy reinstated with an Overweight at JPMorgan
Following a period of restriction, JPMorgan analyst Jeremy Tonet reinstated Cheniere Energy with an Overweight rating and $84 price target. The rating is unchanged and the target is raised from $73 relative to his prior coverage.
10/31/18
10/31/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. CVR Energy (CVI) initiated with a Buy at Citi. 2. Cheniere Energy (LNG) reinstated with an Overweight at JPMorgan. 3. Eidos Therapeutics (EIDX) initiated with a Buy at Roth Capital. 4. NV5 Global (NVEE) and GSE Systems (GVP) were initiated with a Buy at Maxim. 5. Nexa Resources (NEXA) initiated with an Outperform at National Bank. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
10/10/18
FBCO
10/10/18
INITIATION
Target $91
FBCO
Outperform
Cheniere Energy initiated with an Outperform at Credit Suisse
Credit Suisse analyst Spiro Dounis initiated Cheniere Energy with an Outperform rating and a price target of $91.
10/10/18
FBCO
10/10/18
INITIATION
FBCO
Outperform
Credit Suisse bullish on select Oil Midstream stocks on valuation and output
As reported earlier, Credit Suisse analyst Spiro Dounis initiated coverage of 39 midstream oil market stocks, calling DCP Midstream (DCP), Cheniere Energy (LNG), Kinder Morgan (KMI), and MPLX (MPLX) his "top picks". The analyst that his generally "constructive view" is based on expectations of domestic oil and gas production remaining strong as well as his assessment of midstream stocks being "undervalued on several metrics". Dounis adds that he is especially positive on the stocks with leverage to the export market, anticipating "vast majority of marginal production" to clear through the exports. For DCP Midstream, the analyst is positive on the growth project backlog in the DJ and Permian Basin, while for Cheniere Energy, he expects the company's EBITDA and free cash flow generation to ramp up. For Kinder Morgan, Dounis sees a "compelling" capital return story trading at a discount thanks to the company's $6B project backlog expected to drive a 25% distribution growth with an eye on exports.
CVI CVR Energy
$37.97

-0.53 (-1.38%)

10/31/18
SBSH
10/31/18
INITIATION
Target $48
SBSH
Buy
CVR Energy initiated with a Buy at Citi
Citi started CVR Energy with a Buy rating and $48 price target.
10/31/18
SBSH
10/31/18
INITIATION
Target $48
SBSH
Buy
Citi sees CVR Energy as takeover target, starts with Buy rating
Citi analyst Prashant Rao started CVR Energy (CVI) with a Buy rating and $48 price target. The company could be a takeover target, "sufficiently proximate to justify a premium in shares today," Rao tells investors in a research note. He says that as the parent of CVR Refining (CVRR), CVR Energy "comprises two Midwest refineries that are highly complex, with access both to cost-advantaged feedstocks and a strong Midwest refined products market." The analyst notes that his $48 target implies a "lower-end" EBITDA take-out multiple and that CVR Energy has been open about potential deals.
11/06/18
GSCO
11/06/18
DOWNGRADE
Target $45
GSCO
Neutral
CVR Energy downgraded to Neutral from Buy at Goldman Sachs
Goldman Sachs analyst Neil Mehta downgraded CVR Energy to Neutral and lowered his price target for the shares to $45 from $47. Following the recent outperformance of the shares, the analyst sees better investment opportunities elsewhere in the sector. He cites valuation for the downgrade to Neutral.
HLF Herbalife Nutrition
$54.70

-0.35 (-0.64%)

10/11/18
10/11/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Sage Therapeutics (SAGE) initiated with an Outperform at Oppenheimer. 2. Herbalife Nutrition (HLF) initiated with a Buy at Jefferies. 3. GreenSky (GSKY) initiated with a Buy at BTIG. 4. Nightstar Therapeutics (NITE) initiated with an Overweight at Cantor Fitzgerald. 5. KLX Energy (KLXE) initiated with a Buy at Gabelli. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
10/11/18
10/11/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. JPMORGAN UPGRADES LUMENTUM AFTER SELLOFF: JPMorgan analyst Samik Chatterjee upgraded Lumentum (LITE) to Overweight from Neutral with an unchanged price target of $80. The 19% stock decline from the highs in late August, driven by concerns relative to U.S.-China trade, over-appreciates the "modest risks" for Lumentum, Chatterjee said. He believes this creates an "attractive buying opportunity" to capitalize on the near-term improvement in the earnings outlook. GOLDMAN CUTS HUNTINGTON TO SELL: Goldman Sachs analyst Noah Poponak downgraded Huntington Ingalls Industries (HII) to Sell from Neutral and lowered his price target for the shares to $208 from $220. Poponak said Huntington is now the most expensive stock in his Defense coverage on economic, price-to-earnings and free cash flow yield. The analyst believes the stock could underperform Defense peers in the medium-term given the valuation. JEFFRIES STARTS HERBALIFE WITH A BUY: Jefferies analyst Akshay Jagdale started Herbalife Nutrition (HLF) with a Buy rating and $65 price target. After a period of "muted growth," Herbalife's sales looked poised to accelerate to a more normalized range of 5%-9%, Jagdale believes. He thinks the company should be able to grow at least in line with its total addressable market growth rate of 6%. This, coupled with margin expansion and accretive free cash flow usage, should drive "significant" earnings upside and support a "growth company valuation," Jagdale said. JPMORGAN RAISES PRICE TARGET ON NY TIMES: JPMorgan analyst Alexia Quadrani raised her price target for New York Times (NYT) to $32 and reiterated an Overweight rating on the shares ahead of the company's Q3 results. The analyst said that while quarterly subscriber growth may continue to be volatile, the company's longer-term trends are positive. She expects New York Times' growth to "remain at elevated levels for the foreseeable future." SNAP PRICE TARGET CUT AT GOLDMAN SACHS: Goldman Sachs analyst Heath Terry lowered his price target for Snap (SNAP) to $11 from $17, while reiterating a Buy rating on the shares. With Snap shares down 50% since the company reported Q2 results, beyond the broader weakness in social media, the analyst believes investors are clearly focused on the impact competition is having on the company's user growth, ability to monetize, and capital needs. Terry continues to believe that a Twitter-like (TWTR) turnaround is possible, particularly as the new Android app comes out of Alpha later this quarter. However, it is unlikely that Q3 results will show any signs of that as reported DAUs decline and engagement is negatively impacted by the redesign/competition, he said.
10/09/18
DADA
10/09/18
INITIATION
Target $92
DADA
Buy
Nu Skin initiated with a Buy at DA Davidson
DA Davidson analyst Linda Bolton Weiser initiated Nu Skin (NUS) with a Buy rating and a price target of $92, forecasting a 13% organic sales growth and 24% earnings growth in FY18. The analyst notes the achievements of the company's new CEO and CFO in shifting its focus to customer acquisition through "engaging Platforms that leverage social selling, enabling Products that are demonstrable online, and empowering programs to optimize sales performance." Weiser also points to Nu Skin's attractive valuation at 9.0-times her expected FY19 EBITDA - a discount to Herbalife (HLF) and USANA (USNA) which trade around 11-times.
10/11/18
JEFF
10/11/18
INITIATION
Target $65
JEFF
Buy
Herbalife Nutrition initiated with a Buy at Jefferies
Jefferies analyst Akshay Jagdale started Herbalife Nutrition with a Buy rating and $65 price target. After a period of "muted growth," Herbalife's sales looked poised to accelerate to a more normalized range of 5%-9%, Jagdale tells investors in a research note. He thinks the company should be able to grow at least in line with its total addressable market growth rate of 6%. This, coupled with margin expansion and accretive free cash flow usage, should drive "significant" earnings upside and support a "growth company valuation," Jagdale contends.

TODAY'S FREE FLY STORIES

LLY

Eli Lilly

$111.63

0.2 (0.18%)

21:03
08/22/19
08/22
21:03
08/22/19
21:03
Hot Stocks
Arbitration panel rules in favor of Eli Lilly in Adocia IP claim »

A Chicago-based…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

  • 16

    Sep

  • 02

    Oct

  • 23

    Oct

FL

Foot Locker

$42.00

2.24 (5.63%)

, HIBB

Hibbett Sports

$17.01

0.845 (5.23%)

20:25
08/22/19
08/22
20:25
08/22/19
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

FL

Foot Locker

$42.00

2.24 (5.63%)

HIBB

Hibbett Sports

$17.01

0.845 (5.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

  • 23

    Aug

  • 19

    Sep

  • 25

    Sep

RGR

Sturm, Ruger

$41.48

0.69 (1.69%)

, AOBC

American Outdoor Brands

$7.69

-0.01 (-0.13%)

19:40
08/22/19
08/22
19:40
08/22/19
19:40
Hot Stocks
Trump 'hopeful' to work with Congress on' legislation addressing mass shootings »

President Donald Trump…

RGR

Sturm, Ruger

$41.48

0.69 (1.69%)

AOBC

American Outdoor Brands

$7.69

-0.01 (-0.13%)

VSTO

Vista Outdoor

$5.33

0.26 (5.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Aug

  • 10

    Sep

  • 19

    Sep

TOT

Total

$48.98

-0.18 (-0.37%)

19:16
08/22/19
08/22
19:16
08/22/19
19:16
Downgrade
Total rating change at Citi »

Total downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMPR

Kemper

$75.42

0.48 (0.64%)

19:14
08/22/19
08/22
19:14
08/22/19
19:14
Downgrade
Kemper rating change at William Blair »

Kemper downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 10

    Sep

  • 11

    Sep

CRM

Salesforce

$148.26

0.86 (0.58%)

, INTU

Intuit

$276.05

-0.29 (-0.10%)

18:52
08/22/19
08/22
18:52
08/22/19
18:52
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS: …

CRM

Salesforce

$148.26

0.86 (0.58%)

INTU

Intuit

$276.05

-0.29 (-0.10%)

PVTL

Pivotal Software

$13.69

0.01 (0.07%)

CBLK

Carbon Black

$24.52

1.77 (7.78%)

HPQ

HP Inc.

$18.91

-0.04 (-0.21%)

RAVN

Raven

$31.36

-0.87 (-2.70%)

VMW

VMware

$148.15

0.11 (0.07%)

ROST

Ross Stores

$107.31

1.63 (1.54%)

GPS

Gap

$17.75

0.79 (4.66%)

HAS

Hasbro

$114.35

-1.06 (-0.92%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 22

    Aug

  • 22

    Aug

  • 22

    Aug

  • 22

    Aug

  • 22

    Aug

  • 22

    Aug

  • 28

    Aug

  • 28

    Aug

  • 04

    Sep

  • 10

    Sep

  • 25

    Sep

  • 10

    Oct

  • 27

    Oct

  • 12

    Dec

  • 16

    Dec

TLND

Talend

$39.24

0.12 (0.31%)

18:45
08/22/19
08/22
18:45
08/22/19
18:45
Hot Stocks
Talend CEO: We solve the first mile in the data journey »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$354.47

14.44 (4.25%)

18:40
08/22/19
08/22
18:40
08/22/19
18:40
Periodicals
FAA intends to test Boeing MAX software on newer pilots, Reuters says »

Next month, the FAA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Sep

DB

Deutsche Bank

$7.17

0.155 (2.21%)

18:32
08/22/19
08/22
18:32
08/22/19
18:32
Periodicals
Deutsche Bank to pay $16M to settle corruption charges with SEC, Reuters says »

The SEC said that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$292.36

-0.04 (-0.01%)

18:28
08/22/19
08/22
18:28
08/22/19
18:28
Periodicals
Kudlow says U.S., Chinese negotiators held productive trade talks, Reuters says »

White House economic…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$292.36

-0.04 (-0.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$1,188.53

-2.26 (-0.19%)

, GOOGL

Alphabet Class A

$1,190.41

0.15 (0.01%)

18:25
08/22/19
08/22
18:25
08/22/19
18:25
Hot Stocks
Google disabled 210 YouTube channels related to ongoing Hong Kong protests »

Google (GOOG) said in a…

GOOG

Alphabet

$1,188.53

-2.26 (-0.19%)

GOOGL

Alphabet Class A

$1,190.41

0.15 (0.01%)

FB

Facebook

$182.08

-1.48 (-0.81%)

TWTR

Twitter

$42.17

-0.63 (-1.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Sep

  • 24

    Sep

  • 27

    Oct

NUAN

Nuance

$17.31

-0.14 (-0.80%)

18:24
08/22/19
08/22
18:24
08/22/19
18:24
Syndicate
Nuance files Form 10 registration statement for planned spin-off of Cerence »

Nuance Communications…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRM

Salesforce

$148.26

0.86 (0.58%)

18:23
08/22/19
08/22
18:23
08/22/19
18:23
Hot Stocks
Salesforce co-CEO: We had a very strong second quarter »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 28

    Aug

  • 28

    Aug

  • 12

    Dec

  • 16

    Dec

RVLT

Revolution Lighting

$0.34

-0.0124 (-3.57%)

18:10
08/22/19
08/22
18:10
08/22/19
18:10
Hot Stocks
Revolution Lighting discloses additional delisting determination from Nasdaq »

Revolution Lighting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBKC

Iberiabank

$70.16

-0.38 (-0.54%)

18:05
08/22/19
08/22
18:05
08/22/19
18:05
Hot Stocks
Iberiabank CEO Daryl Byrd sells over $840K in company shares »

Iberiabank CEO Daryl Byrd…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

RMNI

Rimini Street

$4.77

-0.11 (-2.25%)

, ORCL

Oracle

$53.18

-0.08 (-0.15%)

18:02
08/22/19
08/22
18:02
08/22/19
18:02
Hot Stocks
San Fang Chemical switches to Rimini Street support for Oracle EBS »

Rimini Street (RMNI)…

RMNI

Rimini Street

$4.77

-0.11 (-2.25%)

ORCL

Oracle

$53.18

-0.08 (-0.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRM

Salesforce

$148.26

0.86 (0.58%)

18:01
08/22/19
08/22
18:01
08/22/19
18:01
Hot Stocks
Salesforce says Customer 360 will be huge growth driver over next decade »

Says: Momentum in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 28

    Aug

  • 28

    Aug

  • 12

    Dec

  • 16

    Dec

AAC

AAC Holdings

$0.60

-0.0327 (-5.17%)

17:57
08/22/19
08/22
17:57
08/22/19
17:57
Hot Stocks
AAC Holdings discloses NYSE listing notice »

AAC Holdings announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

17:32
08/22/19
08/22
17:32
08/22/19
17:32
General news
Fed Balance Sheet Level data reported »

Week of 8/21 Fed Balance…

HPQ

HP Inc.

$18.91

-0.04 (-0.21%)

17:30
08/22/19
08/22
17:30
08/22/19
17:30
Hot Stocks
HP Inc. says notebooks accounted for 39% of revenue in Q3 »

Says supplies category…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 10

    Sep

17:28
08/22/19
08/22
17:28
08/22/19
17:28
General news
Money Supply M2 Weekly Change data reported »

Week of 8/12 Money Supply…

TRPX

Therapix Biosciences

$2.35

(0.00%)

17:27
08/22/19
08/22
17:27
08/22/19
17:27
Syndicate
Breaking Syndicate news story on Therapix Biosciences »

Therapix Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLD

SPDR Gold Shares

$141.38

-0.36 (-0.25%)

17:26
08/22/19
08/22
17:26
08/22/19
17:26
Hot Stocks
SPDR Gold Shares holdings rise to 854.84MT to 851.91MT »

This is the third…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VMW

VMware

$148.15

0.11 (0.07%)

17:19
08/22/19
08/22
17:19
08/22/19
17:19
Earnings
VMware sees Q3 adjusted EPS $1.42, consensus $1.57 »

Sees Q3 revenue growth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 10

    Sep

  • 10

    Oct

CRWD

Crowdstrike

$93.04

-3.5 (-3.63%)

, CBLK

Carbon Black

$24.52

1.77 (7.78%)

17:14
08/22/19
08/22
17:14
08/22/19
17:14
Hot Stocks
Crowdstrike lower after Carbon Black acquisition »

Shares of cybersecurity…

CRWD

Crowdstrike

$93.04

-3.5 (-3.63%)

CBLK

Carbon Black

$24.52

1.77 (7.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.